Corrigendum to “Phenylalanine derivatives as GPR142 agonists for the treatment of Type II diabetes” [Bioorg. Med. Chem. Lett. 22 (2012) 6218–6223]

Corrigendum to ‘‘Phenylalanine derivatives as GPR142 agonists for the treatment of Type II diabetes’’ [Bioorg. Med. Chem. Lett. 22 (2012) 6218–6223] Xiaohui Du a,⇑, Yong-Jae Kim , SuJen Lai , Xi Chen , Mike Lizarzaburu , Simon Turcotte , Zice Fu , Qingxiang Liu , Ying Zhang , Alykhan Motani , Kozo Oda , Ryo Okuyama , Futoshi Nara , Michiko Murakoshi , Angela Fu , Jeff D. Reagan , Peter Fan , Yumei Xiong , Wang Shen , Leping Li , Jonathan Houze , Julio C. Medina a